EUVIMEDEUVIMED entdecken
Crossref

Histoplasmosis screening using urinary antigen detection in people living with HIV in Southern Brazil

Bianca Dos Santos Blan, Vanice Rodrigues Poester iD, Rossana Patricia Basso, Karine Ortiz Sanchotene, Diego H Caceres iD, Ivy Bastos Ramis de Souza, Alessandro C Pasqualotto, Melissa Orzechowski Xavier iD

Medical Mycology · 2025

DOI: 10.1093/mmy/myaf017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Mycology, 2025. Verfasst von Bianca Dos Santos Blan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Pós-graduação em Ciências da Saúde, Faculdade de Medicina (FAMED), Universidade Federal do Rio Grande (FURG), Rio Grande, Brazil, 96203-9…. Hauptthemen laut MEDLINE: Histoplasmosis, Antigens, Fungal, HIV Infections, Mass Screening. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Histoplasmosis is a life-threatening opportunistic infection in individuals with advanced HIV disease, particularly in endemic regions such as Latin America. Early diagnosis is crucial for reducing mortality but remains underdiagnosed due to non-specific clinical presentations and limited diagnostic access. This study evaluates the impact of systematic histoplasmosis screening over 18 months (March 2021–September 2022) using the Histoplasma urinary antigen detection test in people living with HIV (PLHIV) receiving outpatient care or hospitalized at a reference center in Southern Brazil. A retrospective analysis was conducted on PLHIV screened with the Clarus® Histoplasma GM enzyme immunoassay (HGM-EIA, IMMY, USA). Inclusion criteria comprised a recent HIV diagnosis (≤ 30 days), poor adherence to or abandonment of antiretroviral therapy (>90 days), CD4 + count < 200 cells/mm³, or clinical/radiological findings suggestive of histoplasmosis. Clinical, laboratory, and treatment data were assessed, along with 90-day outcomes. Among 287 PLHIV screened, Histoplasma antigen was detected in 9.1% (26/287), including 19.6% of hospitalized patients and 6.4% of outpatients. Overall mortality was 24%, with a higher rate among inpatients (27.3%). Fever, neurological impairment, and lung opacification were more frequent in hospitalized cases. Amphotericin B deoxycholate was more commonly administered to inpatients (63.6% vs. 25%). Mortality at 90 days was significantly higher in patients with a histoplasmosis case-fatality score ≥ 5 (66.7% vs. 33.3%, P = .016). Systematic screening enhances early detection of histoplasmosis, facilitating timely treatment and reducing hospitalizations and mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HistoplasmosisAntigens, FungalHIV InfectionsMass ScreeningAIDS-Related Opportunistic InfectionsHumansBrazilRetrospective StudiesMaleFemaleAdultMiddle AgedHistoplasmaAntifungal AgentsAmphotericin B

Stichwörter der Autor:innen

Histoplasma spp. Histoplasmosisacquired immunodeficiency syndromeantigen detectionhuman immunodeficiency virusopportunistic infections

Substanzen

Antigens, FungalAntifungal AgentsAmphotericin B

Autor:innen und Institutionen

  • Programa de Pós-graduação em Ciências da Saúde, Faculdade de Medicina (FAMED), Universidade Federal do Rio Grande (FURG), Rio Grande, Brazil, 96203-900.
  • Hospital Universitário Dr. Miguel Riet Corrêa Jr. (HU-FURG), Empresa Brasileira de Serviços Hospitalares (EBSERH), Rio Grande, Brazil, 96200-190.
  • IMMY, Norman, OK, USA, 73069.
  • Center of Expertise in Mycology Radboudumc/CWZ, Nijmegen, The Netherlands, 6525.
  • Studies in Translational Microbiology and Emerging Diseases (MICROS) Research Group, Universidad del Rosario, Bogota, Colombia, 111711.
  • Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Brazil, 90050-170.

ORCID-Profile: Vanice Rodrigues Poester, Diego H Caceres, Melissa Orzechowski Xavier

Zitieren

APA

Blan, B. D. S., Poester, V. R., Basso, R. P., Sanchotene, K. O., Caceres, D. H., Ramis de Souza, I. B., Pasqualotto, A. C., & Xavier, M. O. (2025). Histoplasmosis screening using urinary antigen detection in people living with HIV in Southern Brazil. Medical Mycology. https://doi.org/10.1093/mmy/myaf017

Vancouver

Blan BDS, Poester VR, Basso RP, Sanchotene KO, Caceres DH, Ramis de Souza IB, et al. Histoplasmosis screening using urinary antigen detection in people living with HIV in Southern Brazil. Medical Mycology. 2025. doi:10.1093/mmy/myaf017

BibTeX
@article{Blan2025,
  author = {Blan, Bianca Dos Santos and Poester, Vanice Rodrigues and Basso, Rossana Patricia and Sanchotene, Karine Ortiz and Caceres, Diego H and Ramis de Souza, Ivy Bastos and Pasqualotto, Alessandro C and Xavier, Melissa Orzechowski},
  title = {Histoplasmosis screening using urinary antigen detection in people living with HIV in Southern Brazil},
  journal = {Medical Mycology},
  year = {2025},
  doi = {10.1093/mmy/myaf017}
}
Kostenlos starten →